On-demand Webinar: 2020 Social Determinants of Health Series–Assessing and Addressing Social Determinants of Health During a Pandemic
Join us for a webinar featuring KOLs emphasizing applied learnings in the SDOH and population health fields.
Join us for a webinar featuring KOLs emphasizing applied learnings in the SDOH and population health fields.
The Brazilian health system, a mix of private and public payers, predominantly relies on a fee for service model. In order to meet the health care needs of a growing population but also control spending, Brazil needs to evolve its payment models toward value-based health care.
Precision's Avi Mamidi discusses the benefits and obstacles of cutting out health insurance middlemen and moving towards direct partnerships between Integrated Delivery Networks (IDNs) and employers.
Precision's Elizabeth Oyekan identifies four emerging trends in alternative payment models (APM) practices that are enabling APMs to be better prepared to deliver high-quality and more affordable care during the COVID-19 pandemic.
Precision's Andrew Cournoyer discusses our research results on the effects of the shift to virtual negotiations between pharma and payers as a result of the COVID-19 pandemic, and the challenges they face going forward.
Congratulations to the team for being listed as one of the top healthcare agencies of 2020 by MedAd News!
This June marks the 8th annual Cancer Immunotherapy Month led by the Cancer Research Institute to raise awareness of lifesaving immunotherapies. To help support, PRECISIONvalue got together to raise awareness for Immune2Cancer Day!
We are excited to announce that PRECISIONValue has again been featured in MM&M's Agency 100!
COVID-19 has exacerbated fractures in our healthcare and social delivery systems, including adverse social risk factors. Precision's Maureen Hennessey discusses strategies pharmaceutical manufacturers must adopt to address social determinants of health and population health management challenges during the COVID-19 pandemic and beyond.
Congratulations to Precision's Jeremy Schafer, who has been named one of the 2020 PM360 ELITE 100 in the Strategist category!
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ